Novo Nordisk A/S Files for Regulatory Approval of the Ultra-Long-Acting Insulins Degludec and Degludecplus in the US

BAGSVæRD, DENMARK--(Marketwire - September 29, 2011) -

Company Announcement no 61 / 2011: http://hugin.info/2013/R/1551031/477640.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1551031]